1985•PubMedRequires access

[Fundamental data in hemorheology. II. Hyperviscosity syndromes].

Stoltz Jf

Open publisher page 0 citations

Abstract

Whole blood behaves like a deformable colloidal particle suspension in a macromolecular medium. Pathological variations in the rheological properties of blood and the clinical symptoms they produce form the "hyperviscosity syndromes". The term "hyperviscosity" was originally used for characterising the plasma hyperviscosity observed during macroglobulinemia and it is only recently that the chapter covering hyperviscosity syndromes has been enlarged to describe the syndromes as a state in which the increased blood viscosity and increase in flow resistance must be considered as the result of the rheological behaviour of blood taken as a whole (plasma and blood cells). The etiology of hyperviscosity syndromes can be: an increase in total plasma protein levels, or the appearance of a monoclonal protein, the increase in the number of blood cells, the increase in the erythrocyte's internal viscosity, the changes in the erythrocyte's viscoelastic properties, the excessive aggregating tendency of the erythrocytes and perhaps that of the platelets.

About this research paper

What this paper is about

Whole blood behaves like a deformable colloidal particle suspension in a macromolecular medium. Pathological variations in the rheological properties of blood and the clinical symptoms they produce form the "hyperviscosity syndromes". The term "hyperviscosity" was originally used for characterising the plasma hyperviscosity observed during macroglobulinemia and it is only recently that the chapter covering hyperviscosity syndromes has been enlarged to describe the syndromes as a state in which the increased blood viscosity and increase in flow resistance must be considered as the result of the rheological behaviour of blood taken as a whole (plasma and blood cells). The etiology of hyperviscosity syndromes can be: an increase in total plasma protein levels, or the appearance of a monoclonal protein, the increase in the number of blood cells, the increase in the erythrocyte's internal viscosity, the changes in the erythrocyte's viscoelastic properties, the excessive aggregating tendency of the erythrocytes and perhaps that of the platelets.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Whole blood behaves like a deformable colloidal particle suspension in a macromolecular medium. Pathological variations in the rheological properties of blood and the clinical symptoms they produce form the "hyperviscosity syndromes". The term "hyperviscosity" was originally used for characterising the plasma hyperviscosity observed during macroglobulinemia and it is only recently that the chapter covering hyperviscosity syndromes has been enlarged to describe the syndromes as a state in which the increased blood viscosity and increase in flow resistance must be considered as the result of the rheological behaviour of blood taken as a whole (plasma and blood cells). The etiology of hyperviscosity syndromes can be: an increase in total plasma protein levels, or the appearance of a monoclonal protein, the increase in the number of blood cells, the increase in the erythrocyte's internal viscosity, the changes in the erythrocyte's viscoelastic properties, the excessive aggregating tendency of the erythrocytes and perhaps that of the platelets.

Key concepts: Hyperviscosity, Hyperviscosity syndrome, Hemorheology, Blood viscosity, Erythrocyte deformability, Macroglobulinemia, Medicine, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
[Fundamental data in hemorheology. II. Hyperviscosity syndromes]. — Research Paper | ScholarLens